Canadian Cancer Trials Group Bulletins

Trial Management Group


Trials Closed to Accrual

Two trials were recently closed to accrual:

MAC.5 (IBCSG 25-02) -- closed as of today, 11 March 2011
A Phase III Trial Evaluating the Role of Exemestane Plus GnRH Analogue as Adjuvant Therapy for Premenopausal Women with Endocrine Responsive Breast Cancer

IND.190 -- closed 10 March 2011
A Phase I-II Trial of MK-0646, a Monoclonal Antibody Against Insulin-Like Growth Factor-1 Receptor in Combination with Etoposide and Cisplatin in Extensive Stage Small Cell Lung Cancer